CLINICAL IMMUNOBIOCHEMICAL MARKERS IN OPTIMIZING THE DIAGNOSTICS OF BRONCHIAL ASTHMA IN COMORBIDITY WITH TYPE 2 DIABETES MELLITUS. MAJMHS [Internet]. 2025 Nov. 13 [cited 2026 Jan. 30];1(8):51-63. Available from: https://usajournals.org/index.php/1/article/view/1362